A carregar...

Impact of baseline Diabetic Retinopathy Severity Scale scores on visual outcomes in the VIVID-DME and VISTA-DME studies

BACKGROUND/AIMS: To evaluate intravitreal aflibercept versus laser in subgroups of patients with baseline Diabetic Retinopathy Severity Scale (DRSS) scores ≤43, 47, and ≥53 in VIVID-DME and VISTA-DME. METHODS: Patients with diabetic macular oedema were randomised to receive intravitreal aflibercept...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Br J Ophthalmol
Main Authors: Staurenghi, Giovanni, Feltgen, Nicolas, Arnold, Jennifer J, Katz, Todd A, Metzig, Carola, Lu, Chengxing, Holz, Frank G
Formato: Artigo
Idioma:Inglês
Publicado em: BMJ Publishing Group 2018
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6047149/
https://ncbi.nlm.nih.gov/pubmed/29051325
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bjophthalmol-2017-310664
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!